Trupanion (NASDAQ:TRUP) Upgraded to “Buy” at Wall Street Zen

Trupanion (NASDAQ:TRUP – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday, Wall Street Zen reports.

TRUP has been the subject of a number of other reports. Atlantic Securities set a $42.00 target price on Trupanion in a report on Wednesday, July 15th. Stifel Nicolaus upped their price objective on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday, August 20th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. Cantor Fitzgerald decreased their target price on Trupanion from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Wednesday, October 7th. Finally, Weiss Ratings upgraded Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $38.40.

Check Out Our Latest Analysis on TRUP

Trupanion Trading Up 5.8%

Shares of Trupanion stock opened at $36.75 on Friday. Trupanion has a fifty-two week low of $21.16 and a fifty-two week high of $46.98. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The firm has a 50-day simple moving average of $27.14 and a two-hundred day simple moving average of $26.69. The company has a market cap of $1.61 billion, a P/E ratio of 58.02, a price-to-earnings-growth ratio of 1.84 and a beta of 1.27.

Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The financial services provider reported $0.21 EPS for the quarter, topping the consensus estimate of $0.16 by $0.05. The business had revenue of $405.59 million for the quarter, compared to analyst estimates of $402.53 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. During the same period in the previous year, the firm earned $0.13 EPS. As a group, equities analysts predict that Trupanion will post 0.63 earnings per share for the current fiscal year.

Insider Activity

In other Trupanion news, CFO Fawwad Qureshi sold 6,111 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the sale, the chief financial officer owned 4,230 shares in the company, valued at $126,942.30. This represents a 59.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Margaret Tooth sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $25.84, for a total transaction of $25,840.00. Following the completion of the transaction, the chief executive officer owned 184,952 shares in the company, valued at approximately $4,779,159.68. This represents a 0.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 14,046 shares of company stock worth $407,743 over the last three months. 5.58% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Trupanion

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp bought a new stake in Trupanion during the second quarter worth $4,631,000. Bank of America Corp DE purchased a new position in shares of Trupanion during the 2nd quarter valued at about $14,262,000. Renaissancere Holdings Ltd. bought a new position in shares of Trupanion in the 2nd quarter valued at about $6,514,510. Legal & General Group Plc bought a new stake in shares of Trupanion in the 2nd quarter valued at about $1,938,000. Finally, GSA Capital Partners LLP purchased a new position in shares of Trupanion in the second quarter worth about $1,394,000.

Trupanion News Summary

Here are the key news stories impacting Trupanion this week:

  • Positive Sentiment: For Q3 2026, Trupanion reported revenue of $405.6 million, above analysts’ $402.5 million estimate, and EPS of $0.21 versus the $0.16 consensus. EPS also increased from $0.13 a year earlier. Zacks Q3 earnings report
  • Positive Sentiment: Q3 call coverage highlighted record adjusted operating income and cash flow, pointing to operating and cash-generation strengths. Q3 earnings call highlights
  • Neutral Sentiment: Trupanion forecast Q4 revenue of $407 million–$414 million, a range that brackets the $411.9 million consensus. Its FY 2026 revenue guidance of $1.6 billion matched analysts’ estimate, offering little change to the full-year outlook.
  • Negative Sentiment: One earnings recap characterized the quarter as a sharp EPS miss, a caution that may reflect a different earnings measure than the reported $0.21-per-share figure that beat consensus. Q3 earnings recap

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.

See Also

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.